#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Desmoplastic small round cell tumour Hairy cell leukaemia Antiphospholipid antibodies Malignant glioma Polycythaemia vera Microvillous inclusion disease Raynaud's phenomenon Drug eruption Cardiomyopathy Haemophilia B without inhibitors Gastrointestinal disorder Diffuse large B-cell lymphoma Antithrombin III deficiency Thrombotic thrombocytopenic purpura Myxoid liposarcoma More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Diagnostics Haemophilia – Life with Disease Acute respiratory distress syndrome – Basic Information MELAS syndrome – Diagnostics Soft tissue sarcoma – Diagnostics Pulmonary fibrosis – Trials in Disease Ewing’s sarcoma recurrent – Basic Information Mantle cell lymphoma refractory – Treatment Sarcoma – Diagnostics Hereditary angioedema – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MALIC ACID Tropicamide Levosimendan GSKVX000000039711 Heparin Sodium Paeonol Rbl007.2 Abiraterone Acetate Dexibuprofen Histamine Hydrochloride Paracetamol Ph. Eur. Bms-986435 Sasanlimab Ab-729 Bidridistrogene Xeboparvovec DCC-3084 Crizotinib Tislelizumab Plerixafor Cytisine More therapies…

    Learn about Your Condition

    Retinal artery occlusion Ischaemic stroke Autoimmune haemolytic anaemia Tissue anoxia Hepatic neoplasm Overweight Strongyloidiasis Follicular lymphoma stage IV Stevens-Johnson syndrome Hodgkin's disease Depression Haemorrhagic stroke Morning sickness Sickle cell anaemia Cardiac valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cystic fibrosis lung

  • Safety and effectiveness study of inhaled ARCT-032 (mRNA therapy) in adults with Cystic Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cystic fibrosis lung
    Greece Poland

  • Study on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cystic fibrosis lung
    Investigated Drugs:
    • Bi 3720931
    • Gadobutrol
    France Italy The Netherlands Spain

  • Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Bi 3720931
    France Italy The Netherlands Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!